164 related articles for article (PubMed ID: 27473467)
1. [Part III. Clinical control of fenofibrate therapy].
Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():20-5. PubMed ID: 27473467
[No Abstract] [Full Text] [Related]
2. [Fibrates therapy: Rational use fenofibrate 2016. Executive summary].
Brea A; Millán J; Ascaso JF; Blasco M; Díaz A; González-Santos P; Hernández-Mijares A; Mantilla T; Pedro-Botet JC; Pintó X;
Clin Investig Arterioscler; 2016; 28(6):295-301. PubMed ID: 27609708
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
[No Abstract] [Full Text] [Related]
4. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
Samineni D; Fichtenbaum CJ
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
[TBL] [Abstract][Full Text] [Related]
5. More clinical lessons from the FIELD study.
Fazio S
Cardiovasc Drugs Ther; 2009 Jun; 23(3):235-41. PubMed ID: 19160032
[TBL] [Abstract][Full Text] [Related]
6. The role of fenofibrate in clinical practice.
Zambon A; Cusi K
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
Keech A; Simes RJ; Barter P; Best J; Scott R; Taskinen MR; Forder P; Pillai A; Davis T; Glasziou P; Drury P; Kesäniemi YA; Sullivan D; Hunt D; Colman P; d'Emden M; Whiting M; Ehnholm C; Laakso M;
Lancet; 2005 Nov; 366(9500):1849-61. PubMed ID: 16310551
[TBL] [Abstract][Full Text] [Related]
8. Summarizing the FIELD study: lessons from a 'negative' trial.
Tsimihodimos V; Mikhailidis DP; Elisaf M
Expert Opin Pharmacother; 2013 Dec; 14(18):2601-10. PubMed ID: 24206060
[TBL] [Abstract][Full Text] [Related]
9. [Indications for the combination of pravastatin and fenofibrate according to the type of dyslipidemia].
Núñez-Cortés JM
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():31-4. PubMed ID: 25043545
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate and Dyslipidemia: Still a Place in Therapy?
Tarantino N; Santoro F; Correale M; De Gennaro L; Romano S; Di Biase M; Brunetti ND
Drugs; 2018 Sep; 78(13):1289-1296. PubMed ID: 30159817
[TBL] [Abstract][Full Text] [Related]
11. [The fixed combination of pravastatin and fenofibrate: what can it provide?].
Díaz Rodríguez Á
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():12-6. PubMed ID: 25043541
[TBL] [Abstract][Full Text] [Related]
12. [Field, a randomized clinical trial of cardiovascular prevention with fenofibrate in type 2 diabetes].
Radermecker RP; Scheen AJ
Rev Med Liege; 2005 Dec; 60(12):957-61. PubMed ID: 16457397
[TBL] [Abstract][Full Text] [Related]
13. Xanthomata striata palmaris regression with fenofibrate in type III dyslipoproteinemia: A clinical report.
Sampietro T; Sbrana F; Bigazzi F; Dal Pino B; Luciani R; Pianelli M; Marconcini C; Pisciotta L
Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):848-50. PubMed ID: 27263443
[No Abstract] [Full Text] [Related]
14. Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.
Filippatos TD; Elisaf MS
Expert Opin Pharmacother; 2011 Aug; 12(12):1945-58. PubMed ID: 21736529
[TBL] [Abstract][Full Text] [Related]
15. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
Pérez A
Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
[No Abstract] [Full Text] [Related]
16. [Efficacy studies].
Pedro-Botet J; Flores-Le Roux JA
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():17-9. PubMed ID: 25043542
[TBL] [Abstract][Full Text] [Related]
17. Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.
Kei A; Liberopoulos E; Tellis K; Rizzo M; Elisaf M; Tselepis A
Eur J Clin Invest; 2013 Jul; 43(7):698-707. PubMed ID: 23600368
[TBL] [Abstract][Full Text] [Related]
18. [Combination of pravastatin and fenofibrate (Pravafenix ®). Safety studies].
Hernández Mijares A
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():25-30. PubMed ID: 25043544
[TBL] [Abstract][Full Text] [Related]
19. [Achievement of therapeutic objectives].
Mantilla T
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():20-4. PubMed ID: 25043543
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of alternate day therapy with atorvastatin and fenofibrate combination in mixed dyslipidemia: a randomized controlled trial.
Harivenkatesh N; David DC; Haribalaji N; Sudhakar MK
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):296-303. PubMed ID: 24516261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
